Skip to main content

Animations

MJFF Publications

2161 - 2170 of 8620 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2024
  • 2025
  • Summary Details
    OPEN
    Title: Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.tjpad.2025.100133
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-025-60134-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00945-w
    Citation Count: 0
  • Summary Details
    OPEN
    Title: T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01001-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parp1 deletion rescues cerebellar hypotrophy in xrcc1 mutant zebrafish
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-025-01870-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: An atlas of protein phosphorylation dynamics during interferon signaling
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2412990122
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: RNApysoforms: fast rendering interactive visualization of RNA isoform structure and expression in Python
    Journal Name: Bioinformatics Advances
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioadv/vbaf057
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genes
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf032
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Expanding the phenotype of PPP1R21‐related neurodevelopmental disorder
    Journal Name: Clinical Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/cge.14492
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adt2050
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.